111 related articles for article (PubMed ID: 24340464)
21. Nail disorders as signs of pediatric systemic disease.
Shah KN; Rubin AI
Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):204-11. PubMed ID: 22884027
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced onycholysis.
Makris A; Mortimer P; Powles TJ
Eur J Cancer; 1996 Feb; 32A(2):374-5. PubMed ID: 8664062
[No Abstract] [Full Text] [Related]
23. Modulation of linear nail growth to treat diseases of the nail.
Geyer AS; Onumah N; Uyttendaele H; Scher RK
J Am Acad Dermatol; 2004 Feb; 50(2):229-34. PubMed ID: 14726877
[TBL] [Abstract][Full Text] [Related]
24. Toxicoderma caused by hydroxyurea.
Serrano-Falcón C; Pugnaire MAF; Del Mar Serrano-Falcón M; Morales MG; Serrano-Ortega S
Int J Dermatol; 2011 Nov; 50(11):1435-1437. PubMed ID: 22004505
[No Abstract] [Full Text] [Related]
25. Proximal nail fold-lunula double punch technique: a less invasive method for sampling nail matrix without nail avulsion.
Kim JE; Ahn HS; Cheon MS; Lee KJ; Cho BK; Park HJ
Indian J Dermatol Venereol Leprol; 2011; 77(3):346-8. PubMed ID: 21508584
[No Abstract] [Full Text] [Related]
26. [Cutaneous side effects of antitumor chemotherapy].
Delaunay M
Ann Dermatol Venereol; 1989; 116(4):347-61. PubMed ID: 2528934
[No Abstract] [Full Text] [Related]
27. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
28. [Unilateral leukopathia unguis toxica and diffuse hair loss after cytostatic perfusion of an extremity].
Zaun H; Omlor G
Hautarzt; 1992 Apr; 43(4):215-6. PubMed ID: 1534553
[TBL] [Abstract][Full Text] [Related]
29. [A woman with 'year rings' on her nails].
Richir MC; Langenhorst BL
Ned Tijdschr Geneeskd; 2011; 155(45):A3437. PubMed ID: 22085562
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous reactions to rheumatological drugs.
Bailin PL; Matkaluk RM
Clin Rheum Dis; 1982 Aug; 8(2):493-516. PubMed ID: 6216041
[No Abstract] [Full Text] [Related]
31. Case 1. Diffuse melanonychia.
White JM; Higgins EM
Clin Exp Dermatol; 2004 May; 29(3):331-2. PubMed ID: 15115533
[No Abstract] [Full Text] [Related]
32. Onychomadesis: a rare side-effect of valproic acid medication?
Poretti A; Lips U; Belvedere M; Schmitt B
Pediatr Dermatol; 2009; 26(6):749-50. PubMed ID: 20199458
[TBL] [Abstract][Full Text] [Related]
33. "Yellow nail syndrome" and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Arimori S
Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
[TBL] [Abstract][Full Text] [Related]
34. Imatinib: a designer drug, another cutaneous complication.
Dickens E; Lewis F; Bienz N
Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
[TBL] [Abstract][Full Text] [Related]
35. Nail Changes during Chemotherapy.
Alzahrani MF; AlJasser MI
N Engl J Med; 2018 Oct; 379(16):1561. PubMed ID: 30332576
[No Abstract] [Full Text] [Related]
36. Images in clinical medicine. Muehrcke's lines.
Morrison-Bryant M; Gradon JD
N Engl J Med; 2007 Aug; 357(9):917. PubMed ID: 17761595
[No Abstract] [Full Text] [Related]
37. Nail toxicity related to taxanes.
Mourad YA; Matta-Muallem M; Shamseddine A
Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous reactions to propranolol (author's transl)].
Faure M; Hermier C; Perrot H
Ann Dermatol Venereol; 1979 Feb; 106(2):161-5. PubMed ID: 38730
[TBL] [Abstract][Full Text] [Related]
39. [Striated nail discoloration caused by zidovudine].
Bendick C; Rasokat H; Steigleder GK
Z Hautkr; 1989 Feb; 64(2):91-5. PubMed ID: 2718548
[TBL] [Abstract][Full Text] [Related]
40. Transungual drug delivery: current status.
Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
